NCT01962753View on ClinicalTrials.gov

Depression in the Elderly and Cerebral Amyloid Plaques: Characterization by [18F] AV-45 Affectives Symptoms and Amyloïd Plaques (ASAP)

NACompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

May 10, 2012

Primary Completion Date

January 22, 2020

Study Completion Date

January 22, 2020

Conditions
ElderlyMajor Depression
Interventions
DRUG

18FAV45

Admnistration of 18FAV45 if patient is compliant with one of those treatment: Seroplex, Zoloft, Deroxat, Venlafaxine, Mirtazapine, Moclamine,

Trial Locations (10)

14000

University Hospital of Caen, Caen

25030

University Hospital of Besançon- Jean Minjoz, Besançon

31059

University Hospital of Toulouse - Purpan, Toulouse

35000

University hospital of Rennes-Guillaume Régnier, Rennes

37000

University Hospital of Tours, Tours

59000

University Hospital of Lille, Lille

67098

University Hospital of Strasbourg - HUS, Strasbourg

75014

Sainte-Anne Hospital, Paris

76300

Le Rouvray Hospital, Sotteville-lès-Rouen

06000

University Hospital of Nice, Nice

All Listed Sponsors
lead

University Hospital, Tours

OTHER

NCT01962753 - Depression in the Elderly and Cerebral Amyloid Plaques: Characterization by [18F] AV-45 Affectives Symptoms and Amyloïd Plaques (ASAP) | Biotech Hunter | Biotech Hunter